In vivo tests on experimental animals with type 2 diabetes mellitus showed that berberine reduced fasting blood glucose levels and fasting serum insulin levels, increased insulin sensitivity, increased the amount of insulin receptor mRNA, and increased PKC activity in the liver [310]. Here, INS is linked to type 2 diabetes mellitus.